A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer.

Costantine AlbanyZeeshan FazalRatnakar SinghEmmanuel BikorimanaNabil AdraNasser H HannaLawrence H EinhornSusan M PerkinsGeorge E SanduskyBrock C ChristensenHarold KeerFang FangKenneth P NephewMichael J Spinella

Published in: Cancer medicine (2020)

The combination of guadecitabine and cisplatin was tolerable and demonstrated activity in patients with platinum refractory germ cell cancer.

Keyphrases

germ cell
papillary thyroid
squamous cell
squamous cell carcinoma
randomized controlled trial
childhood cancer
young adults
double blind